Status:
COMPLETED
Improving Outcomes and Quality of Life After CABG
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Coronary Artery Bypass Graft Surgery Patients
Eligibility:
All Genders
35-89 years
Phase:
NA
Brief Summary
The principal objective to this randomized trial is to compare the efficacy of two strategies of intra-operative hemodynamic management during cardiopulmonary bypass among patients undergoing primary ...
Detailed Description
In one group, mean arterial pressure (MAP) was 65 mmHg. In the other, the MAP target was determined by the patients usual preoperative MAP. Thus, the trial will evaluate whether tailoring the MAP targ...
Eligibility Criteria
Inclusion
- All patients undergoing primary elective/urgent coronary artery bypass graft (CABG) surgery.
Exclusion
- Patients who elect not to participate in the study
- Patients undergoing valve replacement or other cardiovascular surgical procedures
- Patients who are not fluent in English
- Patient who cannot provide informed written consent
Key Trial Info
Start Date :
December 1 1996
Trial Type :
INTERVENTIONAL
End Date :
December 1 1999
Estimated Enrollment :
412 Patients enrolled
Trial Details
Trial ID
NCT00256620
Start Date
December 1 1996
End Date
December 1 1999
Last Update
April 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States, 10021